The medical home welcomes specialists as new neighbors
The nationwide Patient-Centered Medical Neighborhood (PCMN) pilot project will incorporate outside specialists and hospitals into the Patient-Centered Medical Home (PCMH) concept. A total of 90 primary care practices and 15 health systems will participate in the project, according to TransforMED, a subsidiary of the American Academy of Family Physicians (AAFP).
Leaders of TransforMED, a PCMH consulting and implementation organization, believe the project could lead to a more efficient, coordinated healthcare delivery network that improves care at a lower cost. According to the organization, the first step will be to create the infrastructure and technology needed to allow for data sharing in the first six months, with the goal of seeing clinical results in the following six months.
In attempts to understand current process and identify areas of improvement, TransforMED will meet with practice leaders to assess four areas: costs, health, patient experience, and scalability.
This three-year project, funded by a $20.75 million award by the CMS Center for Medicare and Medicaid Innovation, will involve 15 health systems in 65 cities across the country. It was one of 107 Innovation Challenge grants awarded from more than 3,000 proposals evaluated.
TransforMED plans to attain the following goals by 2015:
Briana Contreras, an editor of Managed Healthcare Executive, spoke with Fred Turner, CEO of Curative, in this month’s episode about the challenges middle-class Americans face in dealing with medical debt, exploring the causes behind it and the impact on overall health.
Listen
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen